Page last updated: 2024-09-05

sb 216763 and Memory Disorders

sb 216763 has been researched along with Memory Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, L; Hui, J; Jiang, D; Mao, X; Pu, M; Shi, G; Wu, J; Xi, G; Zhang, J; Zhou, X; Zou, J1

Other Studies

1 other study(ies) available for sb 216763 and Memory Disorders

ArticleYear
Modulation of GSK-3β/β-Catenin Signaling Contributes to Learning and Memory Impairment in a Rat Model of Depression.
    The international journal of neuropsychopharmacology, 2018, 09-01, Volume: 21, Issue:9

    Topics: Animals; beta Catenin; Cognitive Dysfunction; Corticosterone; Depressive Disorder; Disease Models, Animal; Gene Transfer Techniques; Glycogen Synthase Kinase 3 beta; Hippocampus; Indoles; Intercellular Signaling Peptides and Proteins; Learning Disabilities; Male; Maleimides; Maze Learning; Memory Disorders; Nootropic Agents; Rats, Sprague-Dawley; Signal Transduction; Stress, Psychological; Uncertainty

2018